-
1
-
-
0023624397
-
Determinants of low birth weight: Methodological assessment and meta-analysis
-
Gale EA. Collateral damage: the conundrum of drug safety. Diabetologia 2009;52:1975-82. (Pubitemid 18061811)
-
(1987)
Bulletin of the World Health Organization
, vol.65
, Issue.5
, pp. 663-737
-
-
Kramer, M.S.1
-
2
-
-
0033945075
-
Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight
-
DOI 10.1097/00001648-200007000-00011
-
Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 2011;141:150-6. (Pubitemid 30428936)
-
(2000)
Epidemiology
, vol.11
, Issue.4
, pp. 427-433
-
-
Windham, G.C.1
Hopkins, B.2
Fenster, L.3
Swan, S.H.4
-
3
-
-
34247104181
-
Preterm delivery and exposure to active and passive smoking during pregnancy: A case-control study from Italy
-
DOI 10.1111/j.1365-3016.2007.00815.x
-
Dore DD, Bloomgren GL, Wenten M, Hoffman C, Clifford CR, Quinn SG, et al. A cohort study of acute pancreatitis in relation to exenatide use. Diabetes Obes Metab 2011;13:559-66. (Pubitemid 46597332)
-
(2007)
Paediatric and Perinatal Epidemiology
, vol.21
, Issue.3
, pp. 194-200
-
-
Fantuzzi, G.1
Aggazzotti, G.2
Righi, E.3
Facchinetti, F.4
Bertucci, E.5
Kanitz, S.6
Barbone, F.7
Sansebastiano, G.8
Battaglia, M.A.9
Leoni, V.10
Fabiani, L.11
Triassi, M.12
Sciacca, S.13
-
4
-
-
0034048896
-
A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery
-
Singh S, Chang H-Y, Richard TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med 2013; doi:10. 1001/jamainternmed.2013.2720. (Pubitemid 30127364)
-
(2000)
American Journal of Obstetrics and Gynecology
, vol.182
, Issue.2
, pp. 465-472
-
-
Shah, N.R.1
Bracken, M.B.2
-
5
-
-
0034522773
-
Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
-
Perfetti R, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 2000;141:4600-5.
-
(2000)
Endocrinology
, vol.141
, pp. 46005
-
-
Perfetti, R.1
Zhou, J.2
Doyle, M.E.3
Egan, J.M.4
-
6
-
-
75149182370
-
GLP-1 based therapy for diabetes: What you do not know can hurt you
-
Butler PC, Dry S, Elashoff R. GLP-1 based therapy for diabetes: what you do not know can hurt you. Diabetes Care 2010;33:453-5.
-
(2010)
Diabetes Care
, vol.33
, pp. 453-5
-
-
Butler, P.C.1
Dry, S.2
Elashoff, R.3
-
7
-
-
84864674632
-
Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting
-
Lando HM, Alattar M, Dua AP. Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase- 4 inhibitors in the outpatient setting. Endocr Pract 2012;18:472-7.
-
(2012)
Endocr Pract
, vol.18
, pp. 4727
-
-
Lando, H.M.1
Alattar, M.2
Dua, A.P.3
|